Image

Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease

Understanding Parkinson's early through movement study.

Recruiting
50-75 years
All
Phase N/A

Study Overview: This research aims to improve early diagnosis of Parkinson's Disease (PD) by studying how people move. Researchers will use special tools to see if they can tell apart healthy people from those with PD by the way they move their hands or speak. They will also look at the eyes with advanced techniques to support the diagnosis.

  • Duration: Participants should not take Parkinson's medication 12 hours before the study.
  • Eligibility: Open to people aged 50-75, diagnosed with Parkinsonism or healthy volunteers.
  • Risks: Some tests may involve eye exams, but they are non-invasive and safe.

Key Terms Explained:

Kinematic Theory: Studies how movement works in the body.

Biomarker: A biological sign that can indicate a disease.

Oculovisual: Relating to the eyes and vision.

This study hopes to find more reliable ways to diagnose Parkinson's Disease early, which can help with better treatment planning in the future.

Study details
    Parkinson Disease
    Healthy
    Parkinsonian Syndromes

NCT06161636

Centre hospitalier de l'Université de Montréal (CHUM)

17 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.